Clinical Trials Browser

First-line Advanced NSCLC Patients × Immune Checkpoint Inhibitors × Clear all

NCT07171606 2025-12-18

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Phase 2 Recruiting

First-line Advanced NSCLC Patients